source clinicalSource Clinical is an invaluable guide to the clinical research services sector, supporting pharmaceutical and biotechnology companies with the information they need to progress their drug candidates through the clinical development process.

Source Clinical comprises an extensive compilation of information on companies with the expertise to support and manage clinical research including suppliers of clinical trial quantities of drug products, contract test laboratories, operators of clinical research facilities and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

Through its comprehensive coverage, and with the support of One Nucleus and Bionow, Source Clinical is the reference tool supplying essential information that streamlines the clinical research partner selection process.

Catalent to open second clinical supply facility in China

Catalent logo 16.11.18Catalent Pharma Solutions is to invest $2.5 million in a new, second clinical supply facility in Shanghai, China, due to open in early 2019. When completed, the facility is expected to employ 100 people and will double Catalent’s total clinical storage capacity in China.

The new 30,000 square-feet facility in Tangzhen, a district of Shanghai, will have three controlled temperature rooms operating at 2-8°C, 15-25°C, and -20°C, and will also offer returns and destruction services. The company says that the location for the new facility, outside of the Free Trade Zone (FTZ), will provide clinical trial sponsors with increased speed and efficiency when running trials in China, and that its proximity to Catalent’s existing FTZ facility in Waigaoqiao, within China’s Zhangjiang Pharma Valley, will allow it to offer sponsors an optimised clinical supply solution for studies in both China and beyond.

Catalent will offer its FastChain demand-led supply services from the new facility, as well as from the existing FTZ site, affording sponsors access to in-country GMP secondary packaging, final assembly, labelling and distribution of clinical supplies inside China, and in the wider Asia-Pacific region. These supply services are designed to reduce the time it takes for clinical sites to receive patient kits and to reduce waste from clinical trial material.

The existing Waigaoqiao facility, opened in 2013, provides FTZ access, primary packaging, FastChain supply services, secondary packaging, clinical storage and global distribution services.

For further information about Catalent Pharma Services visit

Last modified onFriday, 16 November 2018 09:18

Latest from Tom Mulligan